Evaluation of an imaging biomarker, Dixon quantitative chemical shift imaging, in Gaucher disease: lessons learned

Journal of Inherited Metabolic Disease

Volumn 37, Issue 6, 2014, Pages 1003-1011

  van Dussen, L ^a   Akkerman, E M ^a   Hollak, C E M ^a   Nederveen, A J ^a   Maas, M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGE; ARTICLE; FOLLOW UP; GAUCHER DISEASE; HUMAN; INFECTION; INTERVERTEBRAL DISK DISEASE; MENOPAUSE; PROTON NUCLEAR MAGNETIC RESONANCE; THERAPY EFFECT; BONE MARROW; CLINICAL TRIAL (TOPIC); FEMALE; LEARNING; LUMBAR VERTEBRA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES;

AGE FACTORS; BIOLOGICAL MARKERS; BONE MARROW; CLINICAL TRIALS AS TOPIC; FEMALE; GAUCHER DISEASE; HUMANS; LEARNING; LUMBAR VERTEBRAE; MAGNETIC RESONANCE IMAGING; MALE; MENOPAUSE;

EID: 84912029037     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-014-9726-3     Document Type: Article

References (34)

1. Clarke BL, Khosla S (2010) Female reproductive system and bone. Arch Biochem Biophys 503:118–128
2. De Roos A, Kressel H, Spritzer C, Dalinka M (1987) Mr imaging of marrow changes adjacent to end plates in degenerative lumbar disk disease. AJR Am J Roentgenol 149:531–534
3. Dixon WT (1984) Simple proton spectroscopic imaging. Radiology 153:189–194
4. Elster AD (1993) Gradient-echo mr imaging: techniques and acronyms. Radiology 186:1–8
5. Grabowski GA, Petsko GA, Kolodny EH (2010) The Online Metabolic & Molecular Bases of Inherited Disease. In: Valle D, Beaudet AL, Vogelstein B, Kinzler K, Antonarakis SE, Ballabio A (eds) Gaucher Disease. McGraw-Hill, New York
6. Hajek PC, Baker LL, Goobar JE et al (1987) Focal fat deposition in axial bone marrow: mr characteristics. Radiology 162:245–249
7. Hollak C, Maas M, Akkerman E, Den Heeten A, Aerts H (2001) Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease. Blood Cells Mol Dis 27:1005–1012
8. Ishijima H, Ishizaka H, Horikoshi H, Sakurai M (1996) Water fraction of lumbar vertebral bone marrow estimated from chemical shift misregistration on mr imaging: normal variations with age and sex. AJR Am J Roentgenol 167:355–358
9. Johnson LA, Hoppel BE, Gerard EL et al (1992) Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease. Radiology 182:451–455
10. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M (2001) Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2:165–171
11. Katz R (2004) Biomarkers and surrogate markers: an Fda perspective. Neurorx 1:189–195
12. Khan A, Hangartner T, Weinreb HJ et al (2012) Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the international collaborative Gaucher group (Icgg) Gaucher registry. J Bone Miner Res 27:1839–1848
13. Maas M, Dijkstra PF, Akkerman EM (1999) Uniform fat suppression in hands and feet through the use of two-point dixon chemical shift imaging. Radiology 210:189–193
14. Maas M, Akkerman EM, Venema HW, Stoker J, Den Heeten GJ (2001) Dixon quantitative chemical shift Mri for bone marrow evaluation in the lumbar spine: a reproducibility study in healthy volunteers. J Comput Assist Tomogr 25:691–697
15. Maas M, Hollak CE, Akkerman EM, Aerts JM, Stoker J, Den Heeten GJ (2002) Quantification of skeletal involvement in adults with type i gaucher’s disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter. AJR Am J Roentgenol 179:961–965
16. Maas M, Van Kuijk C, Stoker J et al (2003) Quantification of bone involvement in Gaucher disease: mr imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift mr imaging–initial experience. Radiology 229:554–561
17. Markl M (2007) Mr physics for clinicians: gradient echo imaging. Ismrm-Esmrmb Joint Annual Meeting Proceedings
18. Meunier P, Aaron J, Edouard C, Vignon G (1971) Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. a quantitative study Of 84 iliac bone biopsies. Clin Orthop Relat Res 80:147–154
19. Miller SP, Zirzow GC, Doppelt SH, Brady RO, Barton NW (1996) Analysis of the lipids of normal and Gaucher bone marrow. J Lab Clin Med 127:353–358
20. Modic MT, Steinberg PM, Ross JS, Masaryk TJ, Carter JR (1988) Degenerative disk disease: assessment of changes in vertebral body marrow with mr imaging. Radiology 166:193–199
21. Poorthuis BJ, Wevers RA, Kleijer WJ et al (1999) The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 105:151–156
22. Roca M, Mota J, Alfonso P, Pocovi M, Giraldo P (2007) S-mri score: a simple method for assessing bone marrow involvement in Gaucher disease. Eur J Radiol 62:132–137
23. Rosen BR, Fleming DM, Kushner DC et al (1988) Hematologic bone marrow disorders: quantitative chemical shift mr imaging. Radiology 169:799–804
24. Rosenthal DI, Doppelt SH, Mankin HJ et al (1995) Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics 96:629–637
25. Smith JJ, Sorensen AG, Thrall JH (2003) Biomarkers in imaging: realizing radiology’s future. Radiology 227:633–638
26. Stevens SK, Moore SG, Amylon MD (1990) Repopulation of marrow after transplantation: mr imaging with pathologic correlation. Radiology 175:213–218
27. Tang GY, Lv ZW, Tang RB et al (2010) Evaluation of mr spectroscopy and diffusion-weighted mri in detecting bone marrow changes in postmenopausal women with osteoporosis. Clin Radiol 65:377–381
28. Tran SD, Terk MR, Colletti PM (2000) Proton mr spectroscopy of bone marrow: precision and reliability. Ajr Am J Roentgenol 174(Suppl):60
29. Van Dussen L, Lips P, Everts VE et al (2011) Markers of bone turnover in Gaucher disease: modeling the evolution of bone disease. J Clin Endocrinol Metab 96:2194–2205
30. Van Dussen L, Zimran A, Akkerman EM et al (2013) Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease. Blood Cells Mol Dis 50:206–211
31. Vom Dahl S, Poll L, Di Rocco M et al (2006) Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients. Curr Med Res Opin 22:1045–1064
32. Wismer GL, Rosen BR, Buxton R, Stark DD, Brady TJ (1985) Chemical shift imaging of bone marrow: preliminary experience. AJR Am J Roentgenol 145:1031–1037
33. Wokke BH, Bos C, Reijnierse M, Van Rijswijk CS et al (2013) Comparison of Dixon and T1-weighted mr methods to assess the degree of fat infiltration in duchenne muscular dystrophy patients. J Magn Reson Imaging 38:619–624
34. Zimran A (2011) How I treat Gaucher disease. Blood 118:1463–1471